Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
carboplatin + Endostar + vinorelbine
- Development stage
- Unknown
- Lead developer
- Simcere Pharmaceutical Group
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Intravenous, Oral
01
Overview
A combination chemotherapy regimen consisting of carboplatin (a platinum-based chemotherapy), Endostar (recombinant human endostatin), and vinorelbine (a vinca alkaloid). This combination targets cancer through multiple mechanisms: carboplatin interferes with DNA replication, Endostar inhibits angiogenesis, and vinorelbine blocks cell division by disrupting microtubules. It is primarily used in the treatment of non-small cell lung cancer (NSCLC), particularly lung squamous cell carcinoma (LSCC).
02
Targets
VEGFR2 (Vascular endothelial growth factor receptor 2)HSPG (Basement membrane-specific heparan sulfate proteoglycan core protein (perlecan))NCL (Nucleolin)DNAITGA5:ITGB1 (Integrin α5β1)VEGFR3 (Vascular endothelial growth factor receptor 3)TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on carboplatin + Endostar + vinorelbine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on carboplatin + Endostar + vinorelbine.